Radiation-induced thyroid diseaseMAXON, H. R.The Medical clinics of North America. 1985, Vol 69, Num 5, pp 1049-1061, issn 0025-7125Article

Radioiodine-131 in the diagnosis and treatment of metastatic well differentiated thyroid cancerMAXON, H. R; SMITH, H. S.Endocrinology and metabolism clinics of North America. 1990, Vol 19, Num 3, pp 685-718, issn 0889-8529, 34 p.Article

A Monte Carlo simulation model for radiation dose to metastatic skeletal tumor from rhenium-186(Sn)-HEDPCHANDRASIRI SAMARATUNGA, R; THOMAS, S. R; HINNEFELD, J. D et al.The Journal of nuclear medicine (1978). 1995, Vol 36, Num 2, pp 336-350, issn 0161-5505Article

Radioiodine-131 therapy for well-differentiated thyroid cancer. A quantitative radiation dosimetric approach : outcome and validation in 85 patientsMAXON, H. R; ENGLARO, E. E; THOMAS, S. R et al.JNM : (1990). 1992, Vol 33, Num 6, pp 1132-1136Article

Imaging modalities in the follow-up of non-iodine avid thyroid carcinomaMALLIN, W. H; ELGAZZAR, A. H; MAXON, H. R et al.American journal of otolaryngology. 1994, Vol 15, Num 6, pp 417-422, issn 0196-0709Article

Reliable preparation of ^99mTc (V) DMSA by a simple modified method using a commercial kit for ^99mTc (III) DMSAWASHBURN, L. C; BINIAKIEWICZ, D. S; MAXON, H. R et al.Nuclear medicine and biology. 1995, Vol 22, Num 5, pp 689-691, issn 0969-8051Article

Outcome after treatment of high-risk papillary and non-Hürthle-cell follicular thyroid carcinomaTAYLOR, T; SPECKER, B; HAY, I et al.Annals of internal medicine. 1998, Vol 129, Num 8, pp 622-627, issn 0003-4819Article

Prospective multicenter Study of Thyroid carcinoma Treatment : Initial analysis of staging and outcomeSHERMAN, S. I; BRIERLEY, J. D; ROBBINS, J et al.Cancer. 1998, Vol 83, Num 5, pp 1012-1021, issn 0008-543XArticle

Rhenium-188(Sn)HEDP for treatment of osseous metastasesMAXON, H. R; SCHRODER, L. E; WASHBURN, L. C et al.The Journal of nuclear medicine (1978). 1998, Vol 39, Num 4, pp 659-663, issn 0161-5505Article

I-123 MIBG scintigraphy in adults: a report of clinical experienceELGAZZAR, A. H; GELFAND, M. J; WASHBURN, L. C et al.Clinical nuclear medicine. 1995, Vol 20, Num 2, pp 147-152, issn 0363-9762Article

Predictive estimate of blood dose from external counting data preceding radioiodine therapy for thyroid cancerTHOMAS, S. R; SAMARATUNGA, R. C; SPERLING, M et al.International journal of radiation applications and instrumentation. Part B. Nuclear medicine and biology. 1993, Vol 20, Num 2, pp 157-162, issn 0883-2897Article

Cancer mortality following treatment for adult hyperthyroidismRON, E; DOODY, M. M; PRESTON-MARTIN, S et al.JAMA, the journal of the American Medical Association. 1998, Vol 280, Num 4, pp 347-355, issn 0098-7484Article

Multimodality imaging of osteomyelitisELGAZZAR, A. H; ABDEL-DAYEM, H. M; CLARK, J. D et al.European journal of nuclear medicine. 1995, Vol 22, Num 9, pp 1043-1063, issn 0340-6997Article

Scintigraphic evaluation of duodenogastric reflux: significance in the diagnosis of acute cholecystitisELGAZZAR, A. H; FERNANDEZ-ULLOA, M; RYAN, J. R et al.American journal of physiologic imaging. 1992, Vol 7, Num 3-4, pp 239-241, issn 0885-8276Article

Thyroid nodularity and chromosome aberrations among women in areas of high background radiation in ChinaWANG, Z; BOICE, J. D; TAN, B et al.Journal of the National Cancer Institute. 1990, Vol 82, Num 6, pp 478-485, issn 0027-8874Article

A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancerHAUGEN, B. R; PACINI, F; DAVIES, T. F et al.The Journal of clinical endocrinology and metabolism. 1999, Vol 84, Num 11, pp 3877-3885, issn 0021-972XArticle

Rhenium-186 hydroxyethylidene diphosphonate for the treatment of painful osseous metastasesMAXON, H. R; THOMAS, S. R; SCHNEIDER, H. J et al.Seminars in nuclear medicine. 1992, Vol 22, Num 1, pp 33-40, issn 0001-2998Article

Rhenium-186(Sn)HEDP for treatment of painful osseous metastases : results of a double-blind crossover comparison with placeboMAXON, H. R; SCHRODER, L. E; SCHNEIDER, H. J et al.JNM. The journal of nuclear medicine : (1990). 1991, Vol 32, Num 10, pp 1877-1881Article

Re-186(Sn) HEDP for treatment of multiple metastatic foci in bone: human biodistribution and dosimetric studiesMAXON, H. R; DEUTSCH, E. A; THOMAS, S. R et al.Radiology. 1988, Vol 166, Num 2, pp 501-507, issn 0033-8419Article

Radiation absorbed-dose estimates for the liver, spleen, and metaphyseal growth complexes in children undergroing gallium-67 citrate scanning = Estimation des doses absorbées par le foie, le rat et les zones de croissance métaphysaires chez les enfants soumis à une scintigraphie au citrate de gallium 67THOMAS, S. R; GELFAND, M. J; BURNS, G. S et al.Radiology. 1983, Vol 146, Num 3, pp 817-820, issn 0033-8419Article

Relation between effective radiation dose and outcome of radioiodine therapy for thyroid cancerMAXON, H. R; THOMAS, S. R; HERTZBERG, V. S et al.The New England journal of medicine. 1983, Vol 309, Num 16, pp 937-941, issn 0028-4793Article